| [1] |
LICCI S.Duodenal localization of plasmablastic myeloma[J]. World J Gastrointest Pathophysiol,2017,8(2):93-95.
|
| [2] |
CHOI Q,KIM H K.Plasmablastic plasma cell myeloma mimicking plasmablastic lymphoma[J]. Korean J Hematol,2010,45(4):223.
|
| [3] |
RAJKUMAR S V,DIMOPOULOS M A,PALUMBO A, et al.International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma[J]. Lancet Oncol,2014,15(12):e538-e548.
|
| [4] |
SAILER M,VYKOUPIL K F,PEEST D,et al.Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma:a histopathological evaluation of biopsies from 153 untreated patients[J]. Eur J Haematol,1995,54(3):137-146.
|
| [5] |
MØLLER H E,PREISS B S,PEDERSEN P,et al. Clinicopathological features of plasmablastic multiple myeloma:a population-based cohort[J]. APMIS,2015,123(8):652-658.
|
| [6] |
BARTL R,FRISCH B,BURKHARDT R,et al.Bone marrow histology in myeloma:its importance in diagnosis,prognosis,classification and staging[J]. Br J Haematol,1982,51(3):361-375.
|
| [7] |
GREIPP P R,RAYMOND N M,KYLE R A,et al. Multiple myeloma:significance of plasmablastic subtype in morphological classification[J]. Blood,1985,65(2):305-310.
|
| [8] |
GREIPP P R,LEONG T,BENNETT J M,et al.Plasmablastic morphology-an independent prognostic factor with clinical and laboratory correlates:Eastern Cooperative Oncology Group(ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group[J]. Blood,1998,91(7):2501-2507.
|
| [9] |
ILIADIS A,KOLETSA T,KOSTOPOULOS I.Aberrant expression of T-cell marker CD7 in HIV negative intestinal plasmablastic lymphoma[J]. Pathology,2016,48(7):731-733.
|
| [10] |
AMMANNAGARI N,CELOTTO K,NEPPALLI V,et al.Anaplastic multiple myeloma:an aggressive variant with a poor response to novel therapies[J]. Clin Lymphoma Myeloma Leuk,2016,16(9):e129-e131.
|
| [11] |
KUMAR S,RAJKUMAR S V,KIMLINGER T,et al.CD45 expression by bone marrow plasma cells in multiple myeloma:clinical and biological correlations[J]. Leukemia,2005,19(8):1466-1470.
|
| [12] |
LIN O,GERHARD R,ZERBINI M C,et al.Cytologic features of plasmablastic lymphoma[J]. Cancer,2005,105(3):139-144.
|
| [13] |
侯著法. Ki-67增殖指数与多发性骨髓瘤预后关系的研究[J]. 湖北民族学院学报(医学版),2004,21(4):6-8.
|
| [14] |
KIM D,PARK C Y,MEDEIROS B C,et al.CD19-CD45 low/-CD38 high/CDl38+ plasma cells enrich for human tumorigenic myeloma cells[J]. Leukemia,2012,26(12):2530-2537.
|
| [15] |
CHAIDOS A,BARNES C P,COWAN G,et al.Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma[J]. Blood,2013,121(2):318-328.
|
| [16] |
TCHERNONOG E,FAURIE P,COPPO P,et al.Clinical characteristics and prognostic factors of plasmablastic lymphoma patients:analysis of 135 patients from the LYSA group[J]. Ann Oncol,2017,28(4):843-848.
|
| [17] |
CHAN K T,CHOI M Y,LAI K K,et al.Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma[J]. Oncol Rep,2014,31(3):1296-1304.
|
| [18] |
VEGA F,CHANG C C,MEDEIROS L J,et al.Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles[J]. Mod Pathol,2005,18(6):806-815.
|
| [19] |
DELECLUSE H J,ANAGNOSTOPOULOS I,DALLENBACH F,et al.Plasmablastic lymphomas of the oral cavity:a new entity associated with the human immunodeficiency virus infection[J]. Blood,1997,89(4):1413-1420.
|
| [20] |
CARBONE A.AIDS-related non-Hodgkin's lymphomas:from pathology and molecular pathogenesis to treatment[J]. Hum Pathol,2002,33(4):392-404.
|
| [21] |
AHN J S,OKAL R,VOS J A,et al.Plasmablastic lymphoma versus plasmablastic myeloma:an ongoing diagnostic dilemma[J]. J Clin Pathol,2017,70(9):775-780.
|
| [22] |
陈嘉利,黎庆恩. Burkitt淋巴瘤细胞骨髓中形态学特征与组织病理学的比较分析[J]. 现代检验医杂志,2005,20(5):30-32.
|
| [23] |
TADDESSE-HEATH L,MELONI-EHRIG A,SCHEERLE J,et al.Plasmablastic lymphoma with MYC translocation:evidence for a common pathway in the generation of plasmablastic features[J]. Mod Pathol,2010,23(7):991-999.
|
| [24] |
XIAO R,CERNY J,DEVITT K,et al.MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance(MGUS)[J]. Am J Surg Pathol,2014,38(6):776-783.
|
| [25] |
BAHMANYAR M,QI X,CHANG H.Genomic aberrations in anaplastic multiple myeloma:high frequency of 1q21(CKS1B) amplifications[J]. Leuk Res,2013,37(12):1726-1728.
|
| [26] |
SETHI S,MILLER I.Plasma cell myeloma with anaplastic transformation[J]. Blood,2016,128(16):2106.
|
